Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

California Sues Companies Over Insulin Prices, Joining Other States

The New York Times – Business:

The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.

Benjamin Ryan
Author: Benjamin Ryan

This post first appeared in The New York Times – Business. Read the original article.

Written by

Benjamin Ryan

in

Diabetes, Drugs (Pharmaceuticals), Health Insurance and Managed Care, Inflation Reduction Act of 2022, Insulin, Law and Legislation, Medicare, Prices (Fares, Fees and Rates), Research, Suits and Litigation (Civil)
←Sade, Snoop Dogg, Teddy Riley Among List Of Inductees For 2023 Songwriters Hall Of Fame
Read Your Way Through Boston→

More posts

  • After Deal to Reopen Strait of Hormuz, Ships Begin to Move Cautiously

  • Plans to end gazumping with binding agreements in house sales shake-up

  • “It’s Latin Maximalism”: Meet Garcias, Milan’s New Menswear Brand

  • Maine resolves ranked choice primaries, setting up the governor’s race and a key House contest

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube